Healthline

Tresiba and Cost: What You Need to Know

Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...
FiercePharma

Tresiba® demonstrates significantly lower rate of hypoglycaemia than insulin glargine in blinded phase 3b trial in people with type 2 diabetes

Bagsværd, Denmark, 29 January 2016 - Novo Nordisk today announced the headline results from SWITCH 2, the first of two 2x32-weeks randomised, double-blind, cross-over, treat-to-target trials, ...
FiercePharma

EASD: Novo Nordisk's Tresiba misses main mark in head-to-head tilt with Sanofi's Toujeo

BARCELONA—Novo Nordisk’s Tresiba is battling it out with Sanofi’s Toujeo in the next-gen insulin category. And while the Danish drugmaker had been hoping to show its contender could top Sanofi’s rival ...
The Business Journals

Novo can't shake Express Scripts' 'non-preferred' status for diabetes drug

New studies on the effectiveness of Novo Nordisk's newest insulin have not been enough to convince Express Scripts to give it preferred status on its formulary. New studies on the effectiveness of ...
Seeking Alpha

Health Canada approves TRESIBA for children with Type 1 diabetes

Novo Nordisk Canada Inc. (NYSE:NVO) announces that TRESIBA (insulin degludec injection) has received an expanded Health Canada approval for the treatment of pediatric patients with Type 1 diabetes ...
Reuters

Novo Nordisk to cut US list prices of two insulin products by more than 70%

COPENHAGEN, Dec 5 (Reuters) - Danish drug maker Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% from January of ...